Alabama: UAB Named to HIV Consortium
July 19, 2005
Last Thursday, the University of Alabama-Birmingham was named one of four institutions in the Center for HIV/AIDS Vaccine Immunology (CHAVI), a collaborative effort to intensify the search for an AIDS vaccine.
Dr. George M. Shaw, who will head UAB's CHAVI team of about 25 researchers, is one of four senior scientific leaders directing CHAVI's work.
The UAB center will focus on understanding what happens in the earliest stages of HIV infection; using new tools to determine how the immune system of the macaque monkey fends off SIV; and creating new HIV vaccines that work at the mucosal surfaces on entryways to the body where HIV transmission occurs.
Last month, Shaw received a $16.3 million grant to do an in-depth study of the human immune system under siege by AIDS. The five-year grant came through the Grand Challenges in Global Health Program, launched in 2003 by the Bill & Melinda Gates Foundation in partnership with the National Institutes of Health.
07.15.05; Dave Parks
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.